FDA Inspection
Reproductive Medicine Associates of New JerseyReproductive Medicine Associates of New Jersey – FDA Inspection, Oct 28, 2021
Record Details
This FDA Inspection record concerns Reproductive Medicine Associates of New Jersey, with an inspection on October 28, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 28, 2021
- Product Type
- Biologics
View Company Profile
ID · daf2a350-632d-434b-bca7-32850aafe333
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1157261
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Reproductive Medicine Associates of New Jersey
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 8, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 8, 2025 | Not classified | New Jersey District Office | |
| August 26, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Medicine Associates of New Jersey
- FDA Inspection 1298482 - 2026-01-08
- FDA Inspection 1283118 - 2025-09-08
- FDA Inspection 1248873 - 2024-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.